Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
CC transcript
Asset disposition
Director departure
Appointed COO
Appointed director
DENDREON CORP (DNDNQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/10/2015 8-K Form 8-K - Current report
06/03/2015 8-K Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Regulation FD Disclosure, Financial Stateme...
Docs: "Confirmation Order of the United States Bankruptcy Court for the District of Delaware"
06/02/2015 8-K Regulation FD Disclosure
05/21/2015 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Monthly Operating Report",
"Second Amended Plan of Liquidation"
04/21/2015 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Monthly Operating Report"
04/17/2015 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Disclosure Statement with Respect to Proposed Plan of Liquidation of Dendreon Corporation, et al.",
"Proposed Plan of Liquidation of Dendreon Corporation, et al.",
"Order entered by the Bankruptcy Court on April 14, 2015"
04/08/2015 8-K Other Events
03/25/2015 8-K Asset disposition
Docs: "Monthly Operating Report"
03/11/2015 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Proposed Plan of Liquidation of Dendreon Corporation, et al.",
"Proposed Disclosure Statement with Respect to Proposed Plan of Liquidation of Dendreon Corporation, et al."
03/06/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Notice of Pendency of Settlement of Action, as approved by the Delaware Court of Chancery on January 16, 2015",
"Stipulation of Compromise and Settlement, entered November 6, 2014"
02/27/2015 8-K Resignation/termination of a director
Docs: "Form of Offer Letter"
02/25/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
02/25/2015 4 Brophy Karen (VP, Human Resources) has filed a Form 4 on DENDREON CORP
Txns: Paid exercise price by delivering 758 shares @ $0.05, valued at $37.9
Paid exercise price by delivering 20,217 shares @ $0.05, valued at $1k
Paid exercise price by delivering 1,137 shares @ $0.05, valued at $56.9
02/23/2015 8-K Resignation/termination of a director
Docs: "Sale Order, entered February 20, 2015"
02/20/2015 8-K Regulation FD Disclosure
02/20/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Second Amended and Restated Acquisition Agreement, by and among Dendreon Corporation, Dendreon Holdings, LLC, Dendreon Distribution, LLC and Dendreon Manufacturing, LLC, Valeant Pharmaceuticals International, Inc. and Drone Acquisition Sub Inc. (Schedules and exhibits have been omitted from this exhibit pursuant to Item 601(b)(2) of Regulation S-K and are not filed herewith. The registrant hereby agrees to furnish a copy of any omitted schedule or exhibits to the U.S. Securities and Exchange Commission upon request.)"
02/19/2015 4 Brophy Karen (VP, Human Resources) has filed a Form 4 on DENDREON CORP
Txns: Sold 2,309 shares @ $0.0723, valued at $166.9
Sold 3,823 shares @ $0.0705, valued at $269.5
02/19/2015 8-K Regulation FD Disclosure
02/18/2015 4 Crotty Robert (EVP, General Counsel) has filed a Form 4 on DENDREON CORP
Txns: Sold 21,764 shares @ $0.0811, valued at $1.8k
02/18/2015 4 Pacheco Silvio (SVP, Sales and Marketing) has filed a Form 4 on DENDREON CORP
Txns: Sold 2,500 shares @ $0.081, valued at $202.5
Sold 3,222 shares @ $0.069, valued at $222.3
02/17/2015 4 Monteith William (EVP, Technical Operations) has filed a Form 4 on DENDREON CORP
02/17/2015 4 Cox Greg (EVP, CFO & Treasurer) has filed a Form 4 on DENDREON CORP
02/17/2015 4 Sandler Andrew Seth (EVP, Chief Medical Officer) has filed a Form 4 on DENDREON CORP
Txns: Sold 7,791 shares @ $0.0904, valued at $704.3
Sold 105,925 shares @ $0.0894, valued at $9.5k
02/17/2015 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Monthly Operating Report",
"Notice of (I) Successful Bidder and of Assumption and Assignment of Executory Contract or Unexpired Lease and (II) Cancellation of Auction, filed February 10, 2015"
02/10/2015 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "DENDREON ANNOUNCES EXPIRATION OF BID DEADLINE IN CONNECTION WITH AGREEMENT TO SELL SUBSTANTIALLY ALL ASSETS TO VALEANT"
02/10/2015 SC 13G/A VANGUARD GROUP INC reports a 0% stake in Dendreon Corp
02/06/2015 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Amended and Restated Acquisition Agreement, by and among Dendreon Corporation, Dendreon Holdings, LLC, Dendreon Distribution, LLC and Dendreon Manufacturing, LLC, and Valeant Pharmaceuticals International, Inc. (Schedules and exhibits have been omitted from this exhibit pursuant to Item 601(b)(2) of Regulation S-K and are not filed herewith. The registrant hereby agrees to furnish a copy of any omitted schedule or exhibits to the U.S. Securities and Exchange Commission upon request.)",
"Order Approving Stalking Horse Bidder, Authorizing Bid Protections in Connection with the Sale of Substantially All of the Debtors' Assets, Rescheduling the Hearing to Approve Such Sale and Granting Related Relief, entered by the United States Bankruptcy Court for the District of Delaware on February 5, 2015",
"DENDREON ENTERS INTO AMENDED AGREEMENT WITH VALEANT IN CONNECTION WITH COURT-SUPERVISED SALES PROCESS"
02/02/2015 4 Crotty Robert (EVP, General Counsel) has filed a Form 4 on DENDREON CORP
Txns: Paid exercise price by delivering 470 shares @ $0.16, valued at $75.2
02/02/2015 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Acquisition Agreement, by and among Dendreon Corporation, Dendreon Holdings, LLC, Dendreon Distribution, LLC and Dendreon Manufacturing, LLC, and Valeant Pharmaceuticals International, Inc. (Schedules and exhibits have been omitted from this exhibit pursuant to Item 601(b)(2) of Regulation S-K and are not filed herewith. The registrant hereby agrees to furnish a copy of any omitted schedule or exhibits to the U.S. Securities and Exchange Commission upon request.)",
"Motion for Order Approving Stalking Horse Bidder, Authorizing Bid Protections in Connection with the Sale of Substantially All of the Debtors' Assets, Rescheduling the Hearing to Approve Such Sale and Granting Related Relief, filed with the United States Bankruptcy Court for the District of Delaware on January 29, 2015",
"DENDREON REACHES AGREEMENT FOR VALEANT TO SERVE AS “STALKING HORSE BIDDER” IN COURT-SUPERVISED SALES PROCESS"
01/27/2015 8-K Regulation FD Disclosure
01/22/2015 8-K Other Events
Docs: "Notice of Pendency of Settlement of Action, as approved by the Delaware Court of Chancery on January 16, 2015"
01/21/2015 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Dendreon Announces Strong Commercial Start to 2015"
01/21/2015 4 Monteith William (EVP, Technical Operations) has filed a Form 4 on DENDREON CORP
01/21/2015 4 Cox Greg (VP, Interim CFO & Treasurer) has filed a Form 4 on DENDREON CORP
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy